Chemoinformaics analysis of DIHYDROXYCINNAMIC-ACID
| Molecular Weight | 180.159 | nRot | 2 |
| Heavy Atom Molecular Weight | 172.095 | nRig | 8 |
| Exact Molecular Weight | 180.042 | nRing | 1 |
| Solubility: LogS | -1.122 | nHRing | 0 |
| Solubility: LogP | 0.32 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 23.5723 |
| nHD | 3 | BPOL | 8.89366 |
| QED | 0.382 |
| Synth | 2.163 |
| Natural Product Likeliness | -0.054 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.007 |
| HIA | 0.103 |
| CACO-2 | -4.984 |
| MDCK | 0.000383417 |
| BBB | 0.632 |
| PPB | 0.768881 |
| VDSS | 0.169 |
| FU | 0.263021 |
| CYP1A2-inh | 0.084 |
| CYP1A2-sub | 0.075 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.108 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.076 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.153 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.211 |
| CL | 2.914 |
| T12 | 0.695 |
| hERG | 0.01 |
| Ames | 0.023 |
| ROA | 0.031 |
| SkinSen | 0.637 |
| Carcinogencity | 0.024 |
| EI | 0.985 |
| Respiratory | 0.727 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.858411 |